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Background: Malaria parasites actively proliferate in the body of their vertebrate and insect hosts, and are
subjected to the toxic effects of reactive oxygen species. The antioxidant defenses of malaria parasites are
considered to play essential roles in their survival and are thus considered promising targets for intervention. We
sought to identify the cellular function of thioredoxin peroxidase-2 (TPx-2), which is expressed in the mitochondria,
by disrupting the TPx-2 gene (pbtpx-2) of the rodent malaria parasite Plasmodium berghei.
Findings: In three independent experiments, two disruptant populations (TPx-2 KO) and three wild-type parasite
populations with pyrimethamine resistance (dhfr-ts/mt at the DHFR-TS locus) and intact pbtpx-2 (TPx-2 WT) were
obtained and cloned. Null expression of TPx-2 in the KO population was confirmed by RT-PCR and Western blot
analyses. The TPx-2 KO parasite developed normally in mouse erythrocytes and multiplied at a rate similar to that of
the TPx-2 WT parasite during the experimental period. The peak period of gametocytemia was delayed by 1 day in
the TPx-2 KO compared with that of the TPx-2 WT and the parent parasite, however, the highest gametocyte
number was comparable. The number of midgut oocysts in the TPx-2 KO at 14 days post feeding was comparable
to that of the TPx-2 WT.
Conclusions: The present finding suggests that mitochondrial Prx TPx-2 is not essential for asexual and the insect
stage development of the malaria parasite.
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Introduction
Malaria is a disease caused by infection with protozoan
parasites of the genus Plasmodium and transmitted by
Anopheles mosquitoes. Almost half of the world’s popula-
tion lives with a serious risk of contacting malaria, and
nearly 1 million people died from the disease in 2010 [1].
Despite years of intensive research, an effective vaccine is
still not available, and the parasite displays increasing resis-
tance towards the commonly used anti-malarial drugs. To
combat malaria, a better understanding of the basic biology
of the parasite is needed, especially with regard to the
mechanisms of adaptation to environmental conditions.* Correspondence: skawazu@obihiro.ac.jp
National Research Center for Protozoan Diseases, Obihiro University of
Agriculture and Veterinary Medicine, Inada, Obihiro 080-8555, Japan
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the Creative Commons Attribution License (ht
distribution, and reproduction in any mediumAs Plasmodium spp. actively proliferate in the erythro-
cytes of their vertebrate hosts, large quantities of reac-
tive oxygen species (ROS), which damage biological
macromolecules, are generated in the cell during para-
site development [2,3]. One of the major sources of ROS
in the parasite cell is heme, which is produced as a
byproduct of hemoglobin digestion for amino acid pro-
curement [4]. In addition, the parasite possesses a mito-
chondrion with a functional electron transport chain.
During respiration, ROS are generated that need to be
removed. ROS also emerge in the cell when the organism
is exposed to a variety of stress conditions such as the ac-
tion of the host immune system [5]. Since Plasmodium
spp. are highly susceptible to oxidative stresses, their anti-
oxidant defenses are considered to play essential roles in
their development, and they are thus expected to be po-
tential targets for chemotherapy [6].ed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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cytoplasm, mitochondrion, apicoplast and nucleus: a 1-Cys
Prx, two typical 2-Cys Prxs, a 1-Cys antioxidant protein
(AOP), a Prx family with unusual biochemical characteris-
tics and a glutathione (GSH) peroxidase-like thioredoxin
peroxidase (TPxGl) [7-9]. Since malaria parasites do not
possess catalase and genuine GSH peroxidase in their
genome, it is considered that GSH itself is the major redox
buffer for transient H2O2 exposure and the basal peroxide
flux in the cell is dealt with by the Trx system [6]. It has
recently been reported that disruption of the gene for the
cytosolic 2-Cys Prx (TPx-1) in Plasmodium renders para-
sites hypersensitive to ROS and reactive nitrogen species,
although it did not affect parasite growth under normal
in vitro and in vivo asexual development [10]. Thus far,
however, the functions of the Prx family in the organelle
are unclear. In the present study, the gene coding for TPx-
2, which is expressed in the mitochondrion of the rodent
malaria parasite P. berghei (Additional file 1: Figure S1), was
disrupted and phenotypes of the disruptant were observed
in experimental infections in mice and mosquitoes in order
to investigate unidentified cellular function of the Prx
family in malaria parasites.
Methods
The P. berghei ANKA strain was obtained from the
Armed Forces Research Institute of Medical Sciences,
Thailand. The parasite was maintained by mosquito
transmission in Anopheles stephensi interspersed by a
maximum of two serial passages in BALB/c mice (Clea
Tokyo, Japan).
For disruption of the pbtpx-2, 50 and 30 portions of the
gene were amplified by polymerase chain reaction (PCR)
and cloned into the targeting vector pMD204 [11],
which was supplied by the Malaria Research and Refer-
ence Reagent Resource Center; MR4/ATCC, Manassas,
VA, USA. Each fragment contained part of the coding
sequence and flanking region and was amplified with
sequence-specific primers and parasite genomic DNA.
The primers used for the 50 fragment were 50–GGG
CCC CTA TCT GAG TAA TAT CTC ATA TCT CC-30
and 50-GAG CTC CAT GAG AAA ACG ATC TCA
CTG ATC-30 (Apa I and Xho I sites are underlined). The
primers used for the 30 fragment were 50-GAA TTC
GTT TAG ACC CAA TAA TGA GGC-30 and 50-CTG
CAG GTT TTT CAC ACA CAG GAG TTA C-30 (Eco
RI and Pst I sites are underlined). The primers were
designed on the basis of sequences in the P. berghei gen-
ome database provided by the Plasmodium Genome
Resource [PlasmoDB: PBANKA_143080]. PCR products
were purified and cloned into the upstream or down-
stream of the pyrimethamine-resistant form of the
P. berghei dihydrofolate reductase-thymidylate synthase
gene (dhfr-ts), which was used as a selectable marker.For gene targeting experiments, the plasmid was
digested with Apa I and Pst I to separate the linear
targeting construct from the plasmid backbone.
Transfection was performed according to the protocol
of Janse et al. [12]. To transfect the knock out construct
into P. berghei with NucleofectorW (Amaxa, Germany),
mature schizonts were prepared. To collect the parasites,
ICR mice (Clea Japan) were infected with P. berghei by
intraperitoneal (i.p.) injection of 5 x 106 parasitized ery-
throcytes per animal. The schizont pellet was resus-
pended in 0.1 ml NucleofectorW working solution
containing 9 μg linearized targeting vector, then trans-
ferred to electroporation cuvettes for transfection at the
U-33 setting. After transfection, 50 μl of complete
culture medium was added to the mixture and was
immediately inoculated into a mouse per transfection by
intravenous (i.v.) injection. The mice were provided with
drinking water containing pyrimethamine (0.7 mg/ml) 1
day after infection with transfected parasites. When
parasitemia had reached 1-2%, the parasite population in
each mouse was examined by allele-specific PCR prior
to cloning the parasite population with the wild-type
and disruptant allele by limiting dilution. Both parasite
genomes were determined by PCR and Southern blot
analyses. Null-phenotype for TPx-2 expression was con-
firmed by reverse transcriptase PCR (RT-PCR) and
Western blotting.
Five–week-old female BALB/c mice (CLEA Japan,
Japan) were infected with P. berghei (106 parasitized
erythrocytes per mouse) by i.p. injection. Parasitemia
and gametocytemia were determined by microscopic
examination of Giemsa-stained thin blood films. Game-
tocytes were distinguished by size and coloration. The
animal experiments in this study were carried out in
compliance with the Guide for Animal Experimentation
at Obihiro University of Agriculture and Veterinary
Medicine (permission numbers: 21–56 and 22–48).
Six-week-old male BALB/c mice (CLEA Japan, Japan)
were infected with P. berghei by i.p. injection of the para-
site, which had been stored as frozen stock at −80°C. Para-
sitemia of each mouse was monitored daily by light
microscopic observation of Giemsa-stained thin blood
smears. A. stephensi mosquitoes were maintained on 10%
sugar solution at 27°C and 80% relative humidity under a
12 hr light/dark cycle. When the number of microgameto-
cytes that could exflagellate in vitro [13] had reached 20–
30 per 1 x 105 erythrocytes, the mosquitoes were fed on
the mice for 2 h at 19°C. The parasite-infected mosquitoes
(100–200 mosquitoes per group) were maintained at 19°C
with 10% sugar solution.
At 14 days post-feeding, mosquitoes that had been
infected with parasite populations were dissected and
their midguts were isolated. The midguts were stained
using the improved technique [14]. Briefly, the midguts
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Japan, Japan) in water at room temperature for 10 min
and washed in PBS for 30 min. Next, stained midguts
were fixed with 10% formalin (Wako Pure Chemical,
Japan) for 24 h and opened along the median line. The
midgut specimens were observed, and the numbers of
red-stained oocysts were counted using light microscopy
(x 100 or x 200).
Differences were evaluated with the Student’s t-test
(mouse infection) or the Mann–Whitney test (mosquito
infection). P < 0.05 was considered statistically significant.
Results and discussion
Merozoites in segmented schizonts were transfected
with the targeting construct by nucleofection and were
subsequently inoculated into naïve mice. Integration of
the construct into the pbtpx-2 locus by homologous
recombination resulted in disruption of the single-copy
gene and insertion of a selectable marker, the dhfr-ts
with a pyrimethamine-resistance mutation (dhfr-ts/mt),
at this locus (Figure 1A). Parasites with pbtpx-2 disrup-
tion were selected by treatment with pyrimethamine.
The allele-specific PCR analysis showed that parasites
selected with pyrimethamine were a mixture of wild-
type parasites and pbtpx-2 disruptants (data not shown).
Parasite populations were separated into two groups by
limiting dilution and subsequent inoculation into 37 rats.
In three independent electroporation experiments, two
disruptant (TPx-2 KO) and three wild-type parasiteFigure 1 Targeted disruption of the tpx-2 gene in P. berghei. (A) The t
and partial open reading frame (hatched boxes) of the pbtpx-2 and the pyr
selectable marker (gray arrow), was integrated into the wild-type (WT) PbTP
Recombination disrupts pbtpx-2 and creates the locus containing dhfr-ts/m
disruptants. (B) Southern blot analysis of genomic DNA samples from the w
mt at the dhfr-ts locus) (TPx-2 WT), and two pbtpx-2 disruptant populations
agarose gels, transferred to nylon membranes, and hybridized with a probe
disruption, whereas the single 7.6-kb band in the TPx-2 WT populations indclones with pyrimethamine resistance (dhfr-ts/mt at the
dhfr-ts locus) and intact pbtpx-2 (TPx-2 WT) were
established. In the first experiment, three TPx-2 WT
clones were obtained. Each TPx-2 KO clone was
obtained from the second and third experiments, re-
spectively. Southern blot analysis confirmed the replace-
ment of the pbtpx-2 locus by the targeting construct in
the TPx-2 KO genome (Figure 1B). Null expression of
TPx-2 in the KO clone was confirmed by RT-PCR and
Western blot analyses (Figure 2). The dhfr-ts locus of
the TPx-2 WT clone was amplified by PCR and
sequenced, and replacement with the pyrimethamine-
resistance mutation was confirmed (data not shown).
In vivo asexual growth was compared in TPx-2 KO and
TPx-2 WTclones. For these experiments, BALB/c mice were
infected with the parasite clones by i.p. injection, and the
course of parasitemia was determined. The TPx-2 WT clone
showed equal levels of development and multiplication
within erythrocytes, similar to the parent strain (WT) (data
not shown), and they showed a high level of parasitemia
(>5%) 4 days after infection (Figure 3A). The course of para-
sitemia observed in TPx-2 KO1-infected mice was similar to
that of TPx-2 WT-infected mice. This phenotype was con-
firmed in TPx-2 KO2, which was obtained from an inde-
pendent electroporation experiment (Figure 3A). There was
no difference in the morphology of parasite cells between
two TPx-2 KO, TPx-2 WT, and WT clones (data not
shown). To evaluate the effect of pbtpx-2 disruption on de-
velopment of sexual-stage parasites, the numbers ofargeting construct, composed of the 50 and 30 regions (filled boxes)
imethamine-resistant variant of dhfr-ts of P. berghei (dhfr-ts/mt) as a
x-2 locus by double-crossover homologous recombination.
t (PbTPx-2 KO locus), which confers pyrimethamine resistance to
ild-type parasite populations with pyrimethamine resistance (dhfr-ts/
(TPx-2 KO). DNA samples were digested with Xba I, separated on 0.7%
. The single 6.2-kb band in the TPx-2 KO populations indicates pbtpx-2
icates an intact pbtpx-2 locus.
Figure 2 Verification of the TPx-2 null phenotype in gene-disrupted P. berghei. WT, TPx-2 WT, and TPx-2 KO parasite populations were
inoculated into mice, and parasite-infected erythrocytes, total protein, and total RNA of the parasite cells were prepared [15]. (A) The absence of
TPx-2-specific mRNA expression in TPx-2 KO was examined by RT-PCR analysis. Total RNA samples (1 μg) were reverse transcribed and the cDNAs
were amplified with the sequence-specific primer pairs that amplify pbtpx-1 (PBANKA_130280) and pbtpx-2 (PBANKA_143080). The primers used
were: 50-CGG AAT TCA TGC CAT CAA TTG TAG GAA ATC AAG CC-30 and 50-GCG GAT CCT TAC AAA CTC GAT AAA TAT TTT TGC AAC TCC-30 for
pbtpx-1, and 50-GGA TCC TCT CAT GTT ACT CAG AAG GC-30 and 50-TAG CCT CGA GTT ACT TTT TGT ATT C-30 for pbtpx-2, respectively.
Amplification of pbtpx-1 but not pbtpx-2 from TPx-2 KO cDNAs indicates the absence of TPx-2-specific mRNA expression in this population.
Molecular size markers in bp are indicated on the left. (B) The absence of TPx-2 protein in TPx-2 KO was examined by Western blot analysis [15].
Total protein samples (5 μg) together with recombinant TPx-2 protein (rTPx-2; 5 ng) were separated by sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis (PAGE; 12.5%) and probed with anti-recombinant PbTPx-2 (rPbTPx-2) rabbit serum (1:1000). Anti-rPbTPx-2
rabbit serum was prepared as previously described [16] except that pGEX-6P-1 (Amersham Biosciences) was used. Protein size markers in kDa are
indicated on the left.
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compared among TPx-2 KO1-2, TPx-2 WT and WT
(Figure 3B). In TPx-2 WT-infected mice, gametocytes were
observed from 2 days after infection; they increased in num-
ber with parasitemia progression and peaked 4 days after in-
fection. The course of gametocytemia observed in TPx-2
WT-infected mice was similar to that of WT-infected mice.
Gametocytemia, recorded as the number of gametocytes/104
erythrocytes in TPx-2 WTand WT-infected mice at 4 day of
infection, was 19.0 ± 12.0 and 26.0 ± 10.0, respectively
(P > 0.05). In TPx-2 KO1-2-infected mice, gametocytes
were also observed from 2 days after infection but peaked 5
days after infection. The peak of gametocytemia in TPx-2Figure 3 Infection of mice with tpx-2-disrupted P. berghei. Parasite pop
and KO2), were inoculated into mice, and the courses of parasite developm
after infection (three mice per group). (B) Changes in gametocytemia 6 da
shown as gametocytes/104 erythrocytes. Data show mean values of parasit
difference in the days required for having the highest gametocyte numberKO-infected mice was thus delayed by 1 day compared
with that of Prx WT- and WT-infected mice. The differ-
ence between WT and TPx-2 KO populations in the num-
ber of days required for having the peak gametocyte
number was significant (P < 0.05). Gametocytemia,
recorded in TPx-2 KO1-2-infected mice as the number of
gametocytes/104 erythrocytes on day 5 of infection, was
28.0 ± 9.0 and 24.0 ± 8.0, respectively. The peak number of
gametocytes in TPx-2 KO1-2-infected mice was thus com-
parable to that of TPx-2 WT-infected mice (P > 0.05).
To investigate the effect of pbtpx-2 disruption in the
insect stage, mosquitoes were fed on parasite infected
BALB/c mice that had been infected with TPx-2 WTulations, including WT, TPx-2 WT and two TPx-2 KO populations (KO1
ent in erythrocytes were observed. (A) Changes in parasitemia 6 days
ys after infection (four mice per group). Gametocyte numbers were
emia percentage (A) and gametocyte number (B). *Significant
between WT and TPx-2 KO populations (P < 0.05; Student’s t-test).
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the mosquitoes were dissected, and oocyst numbers in
the midgut were counted. In this experiment, the num-
ber of midgut oocysts in TPx-2 KO populations at 14
days post-feeding was comparable to those of the TPx-2
WT (P > 0.05) (Figure 4). There was no significant dif-
ference in the developmental stages of oocysts between
TPx-2 KO and TPx-2 WT populations (data not shown),
and this finding suggested that TPx-2 KO oocysts could
develop similarly to those of TPx-2 WT in the midgut.
The results presented here suggest that pbtpx-2 dis-
ruption does not affect asexual intraerythrocytic growth
of parasites. The present findings might be contradicted
by the facts that the mitochondria of the rodent malaria
parasite, P. yoelii, possess an active respiratory chain
[17] and the mitochondrial peroxide-detoxifying capacity
is likely to be provided by Prx [18]. It has also been
reported in other organisms that a mitochondrial Trx
system plays pivotal roles in defense against oxidative
stress generated in the organelle [19].
In P. falciparum, it had been believed for a long time
that the parasite electron transport chain was not a source
of ATP, but was essential in the parasite for maintenance
of mitochondrial membrane potential, as indicated by
their hypersensitivity to proguanil, a drug that collapsed
the membrane potential in the presence of an electron
transport inhibitor [20,21]. However, it has been shown re-
cently that metabolism in P. falciparum grown in human
patients is affected by varied oxygen and substrate levels
and by host-parasite interactions. As a consequence, the
parasite seems to induce expression of genes associatedFigure 4 Number of oocysts per midgut. Data were obtained
from TPx-2 WT and two TPx-2 KO populations (KO1 and KO2). The
line indicates the 95% confidence interval of the mean. The oocyst
formation rate of the TPx-2 KO populations was the same as for the
TPx-2 WT population (P > 0.05; Mann–Whitney test). The number of
mosquitoes dissected was 36 for each experimental group. The
figure shows representative results of three independent
experiments.with oxidative phosphorylation as a response against star-
vation status [22]. The parasite may require TPx-2 for de-
velopment under such stressful conditions. The phenotype
of TPx-2 KO during asexual growth under low glucose
supply would be an interesting subject of investigation.
Plasmodium mitochondria are morphologically differ-
ent between the sexual and asexual blood stages [23].
Asexual stage parasites have a tubular-like cristate mito-
chondrion. In contrast, the mature gametocyte stage has
multiple (4–8) mitochondria with greater numbers of
cristate structures. The differences suggest that the
gametocytes might have a higher demand for energy
transduction and are also more metabolically active than
the asexual stages [23]. Although the contribution of
TPx-2 in gametocyte development remains unknown,
the phenotype of TPx-2 KO in the gametocyte stage is
thus an interesting subject for further investigation.
The results from phenotype observation in the insect
stage suggest that pbtpx-2 disruption does not affect
gamete fertilization, ookinete formation and transform-
ation of the ookinetes to oocysts, which requires ooki-
nete invasion of epithelial cells and attachment to the
basal lamina of the mosquito’s midgut. However, it has
been reported that ookinetes are subject to oxidative
stress during their invasion of midgut epithelial cells
[24]. In addition, it is postulated that ROS is produced
in the motile ookinete stage, when oxygen metabolism
in the cell may be elevated. The expression profiles of
the molecules of the Prx family in the TPx-2 KO ooki-
nete would also be worth investigating.Conclusions
The present finding suggests that mitochondrial Prx
TPx-2 is not essential for the asexual and insect develop-
mental stages of the malaria parasite. Under more pro-
nounced stress conditions, specific functions of TPx-2
may become evident. An explanation for the lack of
phenotype in the TPx-2 KO parasites in the blood and
insect-stages might be due to redundancy in the function
of the multiple members of the thioredoxin system [13].
A multiple Prx KO clone has not yet been produced in
P. berghei. It will be interesting to develop such KO
clones in the future to clarify the Prx family, which may
functionally overlap with TPx-2 in the malaria parasite.Additional file
Additional file 1: Figure S1. Alignment of the deduced amino acid
sequences of Plasmodium berghei TPx-2 (PbTPx-2), with those of TPx-2
from other Plasmodium species.
Abbreviations
GSH: Glutathione; Prx: Peroxiredoxin; TPx: Thioredoxin peroxidase;
ROS: Reactive oxygen species.
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